
Dual HVT recombinant and live attenuated vaccine programs enhance overall protection against ILT and ND
Ivan Alvarado, DVM, PhD, Merck Animal Health, discusses the research which has highlighted the health and production benefits of using recombinant HVT vaccines at the hatchery alongside live vaccines against infectious laryngotracheitis and Newcastle disease.











